Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-047124
Filing Date
2025-03-28
Accepted
2025-03-28 21:47:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8323
  Complete submission text file 0000950170-25-047124.txt   9772
Mailing Address C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Hecht Peter M (Filed by) CIK: 0001478485 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90979 | Film No.: 25788492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)